Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Junhua Wang, Yaoting Shi, Jianbo Chen, Juying Liu, Xiaotian Zhao, Jiaohui Pang, Ximin Sun, Yichen Tian, Qiuxiang Ou, Feng Xia & Yunjie Chen. (2023) Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma. Cancer Biology & Therapy 24:1.
Read now
Read now
Bernardo Stefanini, Matteo Tonnini, Mariarosaria Marseglia & Francesco Tovoli. (2022) Does aspirin use influence hepatocellular carcinoma and cholangiocarcinoma prognosis?. Expert Review of Anticancer Therapy 22:9, pages 887-889.
Read now
Read now
Articles from other publishers (7)
Ka Shing Cheung, Yan Wang Matthew Yeung, Wing Sum Wong, Bofei Li, Wai Kay Seto & Wai K. Leung. (2022) Statins associate with lower risk of biliary tract cancers: A systematic review and meta‐analysis. Cancer Medicine 12:1, pages 557-568.
Crossref
Crossref
Habiba Kamal, Omid Sadr‐Azodi, Lars Engstrand & Nele Brusselaers. (2021) Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population‐Based Cohort Study. Hepatology 74:4, pages 2021-2031.
Crossref
Crossref
Xizi Shen & Xingping Shen. (2020) A potential role for aspirin in the prevention and treatment of cholangiocarcinoma. International Journal of Cancer 148:6, pages 1323-1330.
Crossref
Crossref
Jesus M. Banales, Jose J. G. Marin, Angela Lamarca, Pedro M. Rodrigues, Shahid A. Khan, Lewis R. Roberts, Vincenzo Cardinale, Guido Carpino, Jesper B. Andersen, Chiara Braconi, Diego F. Calvisi, Maria J. Perugorria, Luca Fabris, Luke Boulter, Rocio I. R. Macias, Eugenio Gaudio, Domenico Alvaro, Sergio A. Gradilone, Mario Strazzabosco, Marco Marzioni, Cédric Coulouarn, Laura Fouassier, Chiara Raggi, Pietro Invernizzi, Joachim C. Mertens, Anja Moncsek, Sumera I. Ilyas, Julie Heimbach, Bas Groot Koerkamp, Jordi Bruix, Alejandro Forner, John Bridgewater, Juan W. Valle & Gregory J. Gores. (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology 17:9, pages 557-588.
Crossref
Crossref
Soongu Kwak, You-Jung Choi, Soonil Kwon, Seo-Young Lee, Seokhun Yang, Inki Moon, Hyun-Jung Lee, Heesun Lee, Jun-Bean Park, Kyungdo Han, Yong-Jin Kim & Hyung-Kwan Kim. (2020) De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study. International Journal of Cardiology 313, pages 25-31.
Crossref
Crossref
K Lapumnuaypol, A Tiu, C Thongprayoon, K Wijarnpreecha, P Ungprasert, M A Mao & W Cheungpasitporn. (2019) Reply to: Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis. QJM: An International Journal of Medicine 112:9, pages 721-722.
Crossref
Crossref
M -H Du, K C -W Chu, S -W Cheng, C -H Bai & Y -P Hsu. (2019) Effects of aspirin and non-steroidal anti-inflammatory drugs on the risk of cholangiocarcinoma: a meta-analysis. QJM: An International Journal of Medicine 112:9, pages 719-720.
Crossref
Crossref